A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor

MLA

Farah Rehan, et al. “A Comparative Evaluation of Anti-Tumor Activity Following Oral and Intravenous Delivery of Doxorubicin in a Xenograft Model of Breast Tumor.” Journal of Pharmaceutical Investigation, vol. 52, Sept. 2022, pp. 787–804. EBSCOhost, https://doi.org/10.1007/s40005-022-00595-7.

APA

Farah Rehan, Md. Emranul Karim, Nafees Ahemad, Mohd. Farooq Shaikh, Manish Gupta, Siew Hua Gan, & Ezharul Hoque Chowdhury. (2022). A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor. Journal of Pharmaceutical Investigation, 52, 787–804. https://doi.org/10.1007/s40005-022-00595-7

Chicago

Farah Rehan, Md. Emranul Karim, Nafees Ahemad, Mohd. Farooq Shaikh, Manish Gupta, Siew Hua Gan, and Ezharul Hoque Chowdhury. 2022. “A Comparative Evaluation of Anti-Tumor Activity Following Oral and Intravenous Delivery of Doxorubicin in a Xenograft Model of Breast Tumor.” Journal of Pharmaceutical Investigation 52 (September): 787–804. doi:10.1007/s40005-022-00595-7.